Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus oxytocin plus auriculotherapy for labor duration in primiparous women
IRCT20180415039310N2Phase 4Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxytocin in childbirth (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Length of labor before and after intervention. Started Oct 2019; status: completed.
02
Drugs
oxytocin
03
Conditions
childbirth
Beyond the preview
Go deeper on IRCT20180415039310N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180415039310N2.